Login / Signup

Whole-exome sequencing and host cell reactivation assay lead to a diagnosis of xeroderma pigmentosum group D with mild ultraviolet radiation sensitivity.

Makoto SugayaKaoru FunamizuMichihiro KonoYusuke OkunoTaisuke KondoRyusuke OnoMasashi AkiyamaChikako NishigoriShinichi Sato
Published in: The Journal of dermatology (2020)
A case of xeroderma pigmentosum (XP) group D in a 39-year-old Japanese man is reported. The patient had suffered from moderate to severe solar sensitivity and freckle-like pigmented macules in sun-exposed areas since 6 years of age, and developed skin malignancies such as squamous cell carcinoma, actinic keratosis, Bowen's disease and basal cell carcinoma. The minimal erythema dose for ultraviolet (UV) radiation was decreased with a delayed peak reaction. The level of unscheduled DNA synthesis of fibroblasts from the patient was 70% of normal, while they expressed POLH, a gene product responsible for the XP variant. Whole-exome sequencing indicated that the patient harbored a homozygous mutation of c.1802G>T, p.Arg601Leu in ERCC2. A genetic complementation test was carried out by host cell reactivation assay, which showed that the patient's fibroblasts recovered only when they were transfected with XPD cDNA, confirming the diagnosis of XP-D. Arg601Leu mutation in ERCC2 may be related to mild UV radiation sensitivity and moderate skin lesions.
Keyphrases
  • case report
  • squamous cell carcinoma
  • single cell
  • high throughput
  • dna repair
  • radiation therapy
  • gene expression
  • single molecule
  • dna methylation
  • radiation induced
  • wound healing
  • circulating tumor